IMPORTANCE: Magnetic resonance imaging markers of incipient cognitive decline among healthy elderly individuals have become important for both clarifying the biological underpinnings of dementia and clinically identifying healthy individuals at high risk of cognitive decline. Even though the role of hippocampal atrophy is well known in the later stages of decline, the ability of fornix-hippocampal markers to predict the earliest clinical deterioration is less clear. OBJECTIVES: To examine the involvement of the hippocampus-fornix circuit in the very earliest stages of cognitive impairment and to determine whether the volumes of fornix white matter and hippocampal gray matter would be useful markers for understanding the onset of dementia and for clinical intervention. DESIGN: A longitudinal cohort of cognitively normal elderly participants received clinical evaluations with T1-weighted magnetic resonance imaging and diffusivity scans during repeated visits over an average of 4 years. Regression and Cox proportional hazards models were used to analyze the relationships between fornix and hippocampal measures and their predictive power for incidence and time of conversion from normal to impaired cognition. SETTING: A cohort of community-recruited elderly individuals at the Alzheimer Disease Center of the University of California, Davis. PARTICIPANTS: A total of 102 cognitively normal elderly participants, with an average age of 73 years, recruited through community outreach using methods designed to enhance ethnic diversity. MAIN OUTCOMES AND MEASURES: Our preliminary hypothesis was that fornix white matter volume should be a significant predictor of cognitive decline among normal elderly individuals and that fornix measures would be associated with gray matter changes in the hippocampus. RESULTS: Fornix body volume and axial diffusivity were highly significant predictors (P = .02 and .005, respectively) of cognitive decline from normal cognition. Hippocampal volume was not significant as a predictor of decline but was significantly associated with fornix volume and diffusivity (P = .004). CONCLUSIONS AND RELEVANCE: This could be among the first studies establishing fornix degeneration as a predictor of incipient cognitive decline among healthy elderly individuals. Predictive fornix volume reductions might be explained at least in part by clinically silent hippocampus degeneration. The importance of this finding is that white matter tract measures may become promising candidate biomarkers for identifying incipient cognitive decline in a clinical setting, possibly more so than traditional gray matter measures.
IMPORTANCE: Magnetic resonance imaging markers of incipient cognitive decline among healthy elderly individuals have become important for both clarifying the biological underpinnings of dementia and clinically identifying healthy individuals at high risk of cognitive decline. Even though the role of hippocampal atrophy is well known in the later stages of decline, the ability of fornix-hippocampal markers to predict the earliest clinical deterioration is less clear. OBJECTIVES: To examine the involvement of the hippocampus-fornix circuit in the very earliest stages of cognitive impairment and to determine whether the volumes of fornix white matter and hippocampal gray matter would be useful markers for understanding the onset of dementia and for clinical intervention. DESIGN: A longitudinal cohort of cognitively normal elderly participants received clinical evaluations with T1-weighted magnetic resonance imaging and diffusivity scans during repeated visits over an average of 4 years. Regression and Cox proportional hazards models were used to analyze the relationships between fornix and hippocampal measures and their predictive power for incidence and time of conversion from normal to impaired cognition. SETTING: A cohort of community-recruited elderly individuals at the Alzheimer Disease Center of the University of California, Davis. PARTICIPANTS: A total of 102 cognitively normal elderly participants, with an average age of 73 years, recruited through community outreach using methods designed to enhance ethnic diversity. MAIN OUTCOMES AND MEASURES: Our preliminary hypothesis was that fornix white matter volume should be a significant predictor of cognitive decline among normal elderly individuals and that fornix measures would be associated with gray matter changes in the hippocampus. RESULTS: Fornix body volume and axial diffusivity were highly significant predictors (P = .02 and .005, respectively) of cognitive decline from normal cognition. Hippocampal volume was not significant as a predictor of decline but was significantly associated with fornix volume and diffusivity (P = .004). CONCLUSIONS AND RELEVANCE: This could be among the first studies establishing fornix degeneration as a predictor of incipient cognitive decline among healthy elderly individuals. Predictive fornix volume reductions might be explained at least in part by clinically silent hippocampus degeneration. The importance of this finding is that white matter tract measures may become promising candidate biomarkers for identifying incipient cognitive decline in a clinical setting, possibly more so than traditional gray matter measures.
Authors: Maya K Desai; Michael A Mastrangelo; Deborah A Ryan; Kelly L Sudol; Wade C Narrow; William J Bowers Journal: Am J Pathol Date: 2010-08-09 Impact factor: 4.307
Authors: Maya K Desai; Kelly L Sudol; Michelle C Janelsins; Michael A Mastrangelo; Maria E Frazer; William J Bowers Journal: Glia Date: 2009-01-01 Impact factor: 7.452
Authors: Lin Zhuang; Perminder S Sachdev; Julian N Trollor; Nicole A Kochan; Simone Reppermund; Henry Brodaty; Wei Wen Journal: Neurology Date: 2012-07-25 Impact factor: 9.910
Authors: M W Vernooij; M de Groot; A van der Lugt; M A Ikram; G P Krestin; A Hofman; W J Niessen; M M B Breteler Journal: Neuroimage Date: 2008-08-08 Impact factor: 6.556
Authors: Mark Jenkinson; Christian F Beckmann; Timothy E J Behrens; Mark W Woolrich; Stephen M Smith Journal: Neuroimage Date: 2011-09-16 Impact factor: 6.556
Authors: Laurence O'Dwyer; Franck Lamberton; Arun L W Bokde; Michael Ewers; Yetunde O Faluyi; Colby Tanner; Bernard Mazoyer; Des O'Neill; Máiréad Bartley; D Rónán Collins; Tara Coughlan; David Prvulovic; Harald Hampel Journal: PLoS One Date: 2011-06-30 Impact factor: 3.240
Authors: Adam M Staffaroni; Duygu Tosun; Jue Lin; Fanny M Elahi; Kaitlin B Casaletto; Matthew J Wynn; Nihar Patel; John Neuhaus; Samantha M Walters; Elissa S Epel; Elizabeth H Blackburn; Joel H Kramer Journal: Neurobiol Aging Date: 2018-05-08 Impact factor: 4.673
Authors: Kejal Kantarci; Christopher G Schwarz; Robert I Reid; Scott A Przybelski; Timothy G Lesnick; Samantha M Zuk; Matthew L Senjem; Jeffrey L Gunter; Val Lowe; Mary M Machulda; David S Knopman; Ronald C Petersen; Clifford R Jack Journal: JAMA Neurol Date: 2014-12 Impact factor: 18.302
Authors: Jennifer S Rabin; Rodrigo D Perea; Rachel F Buckley; Keith A Johnson; Reisa A Sperling; Trey Hedden Journal: Neurobiol Aging Date: 2019-05-16 Impact factor: 4.673
Authors: Brian T Gold; Zude Zhu; Christopher A Brown; Anders H Andersen; Mary Jo LaDu; Leon Tai; Greg A Jicha; Richard J Kryscio; Steven Estus; Peter T Nelson; Steve W Scheff; Erin Abner; Frederick A Schmitt; Linda J Van Eldik; Charles D Smith Journal: Neurobiol Aging Date: 2014-05-02 Impact factor: 4.673
Authors: Melissa A Lancaster; Michael Seidenberg; J Carson Smith; Kristy A Nielson; John L Woodard; Sally Durgerian; Stephen M Rao Journal: J Int Neuropsychol Soc Date: 2016-11 Impact factor: 2.892
Authors: James R Bateman; Christopher M Filley; Rini I Kaplan; Kate S Heffernan; Brianne M Bettcher Journal: J Clin Exp Neuropsychol Date: 2019-08-01 Impact factor: 2.475